Finally, BH3BIM also potently induced MOMP when added to permeabilized CLL cells (Fig. S2F), but none of the other peptides, including BH3BAD which targets BCL2, could when they were tested at up to 10 μM. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.